LAFYX
Price
$17.95
Change
+$0.17 (+0.96%)
Updated
Apr 23 closing price
Net Assets
5.59B
VIVAX
Price
$63.78
Change
+$0.44 (+0.69%)
Updated
Apr 23 closing price
Net Assets
190.51B
Ad is loading...

LAFYX vs VIVAX

Header iconLAFYX vs VIVAX Comparison
Open Charts LAFYX vs VIVAXBanner chart's image
Lord Abbett Affiliated I
Price$17.95
Change+$0.17 (+0.96%)
VolumeN/A
Net Assets5.59B
Vanguard Value Index I
Price$63.78
Change+$0.44 (+0.69%)
VolumeN/A
Net Assets190.51B
LAFYX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAFYX vs. VIVAX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAFYX is a Buy and VIVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 191B vs. LAFYX (5.59B). VIVAX pays higher dividends than LAFYX: VIVAX (2.14) vs LAFYX (1.86). LAFYX was incepted earlier than VIVAX: LAFYX (27 years) vs VIVAX (32 years). LAFYX (0.45) is less costly to investors than VIVAX (0.17). LAFYX is a more actively managed with annual turnover of: 57.00 vs. VIVAX (10.00). VIVAX has a lower initial minimum investment than LAFYX: VIVAX (3000) vs LAFYX (1000000). VIVAX annual gain was more profitable for investors over the last year : 2.68 vs. LAFYX (-0.03). VIVAX return over 5 years is better than : 68.72 vs. LAFYX (54.45).
LAFYXVIVAXLAFYX / VIVAX
Total Expense Ratio0.450.17265%
Annual Report Gross Expense Ratio0.450.17265%
Fund Existence27 years32 years-
Gain YTD-4.712-4.092115%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets5.59B191B3%
Annual Yield % from dividends1.862.1487%
Returns for 1 year-0.032.68-1%
Returns for 3 years8.5311.9671%
Returns for 5 years54.4568.7279%
Returns for 10 years23.1990.3726%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEAPX25.92N/A
N/A
Principal Glb Emerging Markets R3
HGHTX39.89N/A
N/A
Hartford Healthcare R5
PASIX10.54N/A
N/A
PACE Alternative Strategies A
FZANX39.11N/A
N/A
Fidelity Advisor New Insights Z
TQVIX16.60N/A
N/A
T. Rowe Price Integrated US LCV Eq I